Steven Juk
Cardiovascular Disease · West Columbia, SCNPI 1932161692
Payments from drug & device makers
Across 257 payments — averaging $14.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$979
- E.r. Squibb & Sons, L.L.C.$470
- Johnson & Johnson$459
- Amgen$438
- Pfizer$397
- Abbott$190
- plus $800 from 18 others
What the payments were for
- Food & beverage$3,718100%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 62 | $979 |
| E.r. Squibb & Sons, L.L.C. | 54 | $470 |
| Johnson & Johnson | 31 | $459 |
| Amgen | 30 | $438 |
| Pfizer | 29 | $397 |
| Abbott | 5 | $190 |
| Regeneron Healthcare Solutions, Inc. | 9 | $138 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $129 |
| Sanofi-aventis U.S. LLC | 5 | $84 |
| Novo Nordisk | 3 | $63 |
| Amarin Pharma, Inc. | 4 | $54 |
| AstraZeneca | 4 | $46 |
| Merck | 3 | $42 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Boehringer Ingelheim | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Irhythm Technologies, Inc. | 1 | $27 |
| Arbor Pharmaceuticals, Inc. | 2 | $24 |
| Akcea Therapeutics, Inc. | 1 | $20 |
| Philips North America LLC | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Boston Scientific | 1 | $17 |
| GSK | 1 | $16 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$176
- Mitra Clip system$136
- ENTRESTO$125
- ELIQUIS$109
How this compares
$3,734 in reported general payments places this provider in the 45th percentile of 257 cardiovascular disease providers in South Carolina.
See all cardiovascular disease providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $12,343 |
| Ezetimibe | 11 | $780 |
| Rosuvastatin Calcium | 25 | $573 |
| Metoprolol Succinate | 13 | $321 |
| Atorvastatin Calcium | 17 | $180 |
| Amlodipine Besylate | 16 | $111 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $397 | $12,34315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 257 cardiovascular disease providers in South Carolina.
Other cardiovascular disease in West Columbia
- Brent McLaurinAnderson$1.1M
- Robert BiedermanCharleston$801K
- James MerriamGreenville$728K
- Vipul ShahLancaster$488K
- Arthur EberlyGreenville$438K
- Gregory SanGreenville$429K
- Naresh MoriRock Hill$408K
- Priya KumarGreenwood$351K
- Dev VazGreenville$257K
- William YarbroughCharleston$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.